Skip to main content
. Author manuscript; available in PMC: 2010 Aug 6.
Published in final edited form as: Vaccine. 2009 May 27;27(36):5020–5025. doi: 10.1016/j.vaccine.2009.05.008

Table 3.

Recovery of C. trachomatis MoPn from the lungs of mice following the i.n. challenge

Immunization Weight of Median IFU (range) recovered
Antigen Adjuvant route lungs (g)a from lungs × (106)
Ct-rMOMP CpG+Montanide i.m.+s.c 0.29±0.06b 1.5 (0.0003 – 6,029) d
Ct-nMOMP CpG+Montanide i.m.+s.c 0.23±0.03 b,c 0.02 (0.003 – 0.2) d,e
Ng-rPorB CpG+Montanide i.m.+s.c 0.35±0.04 3,799 (10 – 18,534)
Live Ct-MoPn - i.n. 0.24±0.03 b 0 (0 – 0.0005) d,ef
MEM-0 - i.n. 0.36±0.03 6,071 (1,899 – 13,339)
a

The values are means ± 1 SD.

b

P<0.05 as determined by the Student t test compared to the mice immunized with Ng-rPorB or MEM-0.

c

P<0.05 as determined by the Student t test compared to the Ct-rMOMP immunized group.

d

P<0.05 as determined by the Mann-Whitney U test compared to the Ng-rPorB or MEM-0 immunized groups.

e

P<0.05 as determined by the Mann-Whitney U test compared to the mice immunized with Ct-rMOMP.

f

P<0.05 as determined by the Mann-Whitney U test compared to the Ct-nMOMP immunized group.